Detailed information for compound 1524632

Basic information

Technical information
  • TDR Targets ID: 1524632
  • Name: 3-tert-butyl-N-(3-imidazol-1-ylpropyl)-4-meth oxybenzenesulfonamide
  • MW: 351.464 | Formula: C17H25N3O3S
  • H donors: 1 H acceptors: 3 LogP: 2.61 Rotable bonds: 8
    Rule of 5 violations (Lipinski): 1
  • SMILES: COc1ccc(cc1C(C)(C)C)S(=O)(=O)NCCCn1cncc1
  • InChi: 1S/C17H25N3O3S/c1-17(2,3)15-12-14(6-7-16(15)23-4)24(21,22)19-8-5-10-20-11-9-18-13-20/h6-7,9,11-13,19H,5,8,10H2,1-4H3
  • InChiKey: VZUYKEDTLKPMAL-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • 3-tert-butyl-N-(3-imidazol-1-ylpropyl)-4-methoxy-benzenesulfonamide
  • 3-tert-butyl-N-[3-(1-imidazolyl)propyl]-4-methoxybenzenesulfonamide
  • ZINC04937453
  • 3-tert-Butyl-N-(3-imidazol-1-yl-propyl)-4-methoxy-benzenesulfonamide
  • ASN 12914683
  • T5580109

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens cytochrome P450, family 19, subfamily A, polypeptide 1 Starlite/ChEMBL References
Homo sapiens SMAD family member 2 Starlite/ChEMBL No references

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Loa Loa (eye worm) transcription factor SMAD2 Get druggable targets OG5_131716 All targets in OG5_131716
Brugia malayi MH2 domain containing protein Get druggable targets OG5_131716 All targets in OG5_131716
Loa Loa (eye worm) MH2 domain-containing protein Get druggable targets OG5_131716 All targets in OG5_131716

By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Trypanosoma cruzi cytochrome P450, putative cytochrome P450, family 19, subfamily A, polypeptide 1 503 aa 425 aa 18.8 %
Brugia malayi MH2 domain containing protein SMAD family member 2 467 aa 405 aa 31.6 %

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Trichomonas vaginalis dihydroorotate dehydrogenase, putative 0.0197 0.3783 0.5
Leishmania major dihydroorotate dehydrogenase 0.0504 1 0.5
Trichomonas vaginalis dihydroorotate dehydrogenase, putative 0.0197 0.3783 0.5
Trichomonas vaginalis dihydropyrimidine dehydrogenase, putative 0.0197 0.3783 0.5
Wolbachia endosymbiont of Brugia malayi dihydroorotate dehydrogenase 2 0.0504 1 0.5
Echinococcus multilocularis dihydropyrimidine dehydrogenase (NADP+) 0.0197 0.3783 1
Schistosoma mansoni dihydroorotate dehydrogenase 0.0504 1 1
Trypanosoma brucei dihydroorotate dehydrogenase (fumarate) 0.0504 1 0.5
Plasmodium falciparum dihydroorotate dehydrogenase 0.0504 1 0.5
Trichomonas vaginalis dihydroorotate dehydrogenase, putative 0.0197 0.3783 0.5
Brugia malayi Zinc finger, C2H2 type family protein 0.0197 0.3783 0.3783
Trichomonas vaginalis dihydroorotate dehydrogenase, putative 0.0197 0.3783 0.5
Brugia malayi Dihydroorotate dehydrogenase, mitochondrial precursor, putative 0.0504 1 1
Echinococcus granulosus dihydropyrimidine dehydrogenase NADP 0.0197 0.3783 1
Loa Loa (eye worm) transcription factor SMAD2 0.0144 0.2721 1
Loa Loa (eye worm) MH2 domain-containing protein 0.0144 0.2721 1
Trichomonas vaginalis dihydroorotate dehydrogenase, putative 0.0197 0.3783 0.5
Trypanosoma cruzi dihydroorotate dehydrogenase, putative 0.0504 1 1
Entamoeba histolytica dihydropyrimidine dehydrogenase, putative 0.0197 0.3783 0.5
Echinococcus multilocularis dihydropyrimidine dehydrogenase (NADP+) 0.0197 0.3783 1
Toxoplasma gondii dihydroorotate dehydrogenase reveal, putative 0.0504 1 0.5
Trypanosoma cruzi dihydroorotate dehydrogenase (fumarate), putative 0.0504 1 1
Echinococcus granulosus dihydropyrimidine dehydrogenase NADP 0.0197 0.3783 1
Mycobacterium leprae Probable dihydroorotate dehydrogenase PyrD 0.0504 1 0.5
Trypanosoma cruzi dihydroorotate dehydrogenase, putative 0.0504 1 1
Plasmodium vivax dihydroorotate dehydrogenase, mitochondrial precursor, putative 0.0504 1 0.5
Brugia malayi MH2 domain containing protein 0.0144 0.2721 0.2721
Mycobacterium tuberculosis Probable dihydroorotate dehydrogenase PyrD 0.0504 1 0.5
Mycobacterium ulcerans dihydroorotate dehydrogenase 2 0.0504 1 0.5

Activities

Activity type Activity value Assay description Source Reference
IC50 (binding) = 440 nM Inhibition of human recombinant aromatase using 7-methoxy-4-trifluoromethyl coumarin as substrate by fluorimetric analysis ChEMBL. 21604760
Potency (functional) 2.8184 uM PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b: Cytotox Counterscreen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588855, AID588860] ChEMBL. No reference
Potency (functional) 3.9811 uM PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860] ChEMBL. No reference
Potency (functional) 11.6891 uM PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] ChEMBL. No reference
Potency (functional) 13.1154 uM PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] ChEMBL. No reference
Potency (functional) 25.929 uM PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of RanGTP induced Rango (Ran-regulated importin-beta cargo) - Importin beta complex dissociation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID540262] ChEMBL. No reference
Potency (functional) 28.1838 uM PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ChEMBL. No reference
Potency (functional) 50.1187 uM PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) ChEMBL. No reference
Potency (functional) 79.4328 uM PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623] ChEMBL. No reference

Phenotypes

Whole-cell/tissue/organism interactions

Species name Source Reference Is orphan
Homo sapiens ChEMBL23
Plasmodium falciparum ChEMBL23

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.